These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23370512)

  • 81. Application of molecular imaging technologies in antitumor drug development and therapy.
    Lin Y; Chen ZY; Yang F; Zhang JS; Wang YX; Liu JB; Liao JY; Liao YY; Zhou QL; Li BC; Liang HY
    Curr Pharm Des; 2015; 21(16):2136-46. PubMed ID: 25578891
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Positron emission tomography imaging of small animals in anticancer drug development.
    Aboagye EO
    Mol Imaging Biol; 2005; 7(1):53-8. PubMed ID: 15912276
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Activities and future directions of PMDA (Pharmaceuticals and Medical Devices Agency)].
    Kondo T
    Nihon Yakurigaku Zasshi; 2012 May; 139(5):211-4. PubMed ID: 22687874
    [No Abstract]   [Full Text] [Related]  

  • 84. Effective use of microdosing and Positron Emission Tomography (PET) studies on new drug discovery and development.
    Sugiyama Y
    Drug Metab Pharmacokinet; 2009; 24(2):127-9. PubMed ID: 19430167
    [No Abstract]   [Full Text] [Related]  

  • 85. Molecular Imaging to Study Antimicrobial Pharmacokinetics In Vivo.
    Gordon O; Gobburu JVS; Dunn A
    J Infect Dis; 2023 Oct; 228(Suppl 4):S297-S301. PubMed ID: 37788503
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Recent progress and challenges in investigator-driven clinical development of novel drugs and medical devices at the University of Tokyo Hospital].
    Arakawa Y
    Yakugaku Zasshi; 2013; 133(2):201-8. PubMed ID: 23370514
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Molecular recognition mechanisms for detecting cell death in vivo.
    Zhao M
    Curr Pharm Biotechnol; 2010 Sep; 11(6):693-700. PubMed ID: 20497108
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Drugs and probes: the symbiotic relationship between pharmaceutical discovery and imaging science.
    Maclean D; Northrop JP; Padgett HC; Walsh JC
    Mol Imaging Biol; 2003; 5(5):304-11. PubMed ID: 14630510
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Positron emission tomography as a research tool for translational science].
    Nishimura S
    Nihon Yakurigaku Zasshi; 2013 Mar; 141(3):136-40. PubMed ID: 23470478
    [No Abstract]   [Full Text] [Related]  

  • 90. [Applications of PET imaging in the preclinical stage of drug development].
    Tsukada H
    Nihon Yakurigaku Zasshi; 2010 Feb; 135(2):80-3. PubMed ID: 20154416
    [No Abstract]   [Full Text] [Related]  

  • 91. Meeting Report: PMDA Public Workshop on Pharmacometrics at Japan.
    Kijima S; Ochiai Y; Ishiguro A
    CPT Pharmacometrics Syst Pharmacol; 2020 Oct; 9(10):550-552. PubMed ID: 32914930
    [No Abstract]   [Full Text] [Related]  

  • 92. [Drug Discovery and Medical Technology Program in RIKEN life science innovation].
    Yamaguchi T
    Nihon Yakurigaku Zasshi; 2013 Nov; 142(5):241-6. PubMed ID: 24212594
    [No Abstract]   [Full Text] [Related]  

  • 93. The Role of Molecular Imaging in Drug Delivery.
    Niu G; Chen X
    Drug Deliv (Lond); 2009; 3():109-113. PubMed ID: 26435748
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The Opportunities and Use of Imaging to Measure Target Engagement.
    Maynard J; Hart P
    SLAS Discov; 2020 Feb; 25(2):127-136. PubMed ID: 31885303
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Multivalent Probes in Molecular Imaging: Reality or Future?
    Böhmer VI; Szymanski W; Feringa BL; Elsinga PH
    Trends Mol Med; 2021 Apr; 27(4):379-393. PubMed ID: 33436332
    [TBL] [Abstract][Full Text] [Related]  

  • 96. In vivo pharmacokinetics and pharmacodynamics in drug development using positron-emission tomography.
    Aboagye EO; Price PM; Jones T
    Drug Discov Today; 2001 Mar; 6(6):293-302. PubMed ID: 11257581
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Positron emission tomography and drug discovery: contributions to the understanding of pharmacokinetics, mechanism of action and disease state characterization.
    Klimas MT
    Mol Imaging Biol; 2002 Oct; 4(5):311-37. PubMed ID: 14537107
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Regulation of pharmacokinetics and targeting-confirmative personalized medicine].
    Kawai K
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2011; 67(3):249-59. PubMed ID: 21471682
    [No Abstract]   [Full Text] [Related]  

  • 99. The curious stories of drugs with two lives: a new paradigm in drug development.
    MacPherson R
    J R Soc Med; 2015 Jul; 108(7):255-8. PubMed ID: 25827907
    [No Abstract]   [Full Text] [Related]  

  • 100. The Roles of Regulatory Science Research in Drug Development at the Pharmaceuticals and Medical Devices Agency of Japan.
    Asahina Y; Tanaka A; Uyama Y; Kuramochi K; Maruyama H
    Ther Innov Regul Sci; 2013 Jan; 47(1):19-22. PubMed ID: 30227480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.